{"id":"NCT00788710","sponsor":"Organon and Co","briefTitle":"A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)","officialTitle":"A Double-Blind, Placebo-Controlled, Multicenter Trial to Study the Efficacy and Tolerability of MK0663/Etoricoxib in the Treatment of Pain After Abdominal Hysterectomy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-10","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2008-11-11","resultsPosted":"2011-07-22","lastUpdate":"2022-02-09"},"enrollment":430,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Pain Following a Total Abdominal Hysterectomy"],"interventions":[{"type":"DRUG","name":"etoricoxib (MK0663) 120 mg","otherNames":["Arcoxia"]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]},{"type":"DRUG","name":"etoricoxib (MK0663) 90 mg","otherNames":[]}],"arms":[{"label":"Etoricoxib 120 mg","type":"EXPERIMENTAL"},{"label":"Etoricoxib 90 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of etoricoxib compared to placebo in the treatment of postoperative pain associated with total abdominal hysterectomy.","primaryOutcome":{"measure":"Average Pain Intensity at Rest Over Days 1 to 3","timeFrame":"3 Days","effectByArm":[{"arm":"Etoricoxib 120 mg","deltaMin":2.4,"sd":0.15},{"arm":"Etoricoxib 90 mg","deltaMin":2.46,"sd":0.15},{"arm":"Placebo","deltaMin":3.26,"sd":0.15}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22738802"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":144},"commonTop":["Nausea","Constipation","Pyrexia","Dizziness","Flatulence"]}}